This content is machine translated Type 2 diabetes and chronic renal failure (CKD) Dapagliflozin: risk reduction even in the presence of greatly increased albumin excretion. About half of all diabetics develop chronic kidney disease. SGLT-2 inhibitors have been shown not only to favorably affect glucose metabolism, but also to protect the heart and kidneys. The…
